New Issue: Pfizer prices $1.07 billion 30-year Taipei Exchange-listed notes at par to yield 4.2%

By Cristal Cody

Tupelo, Miss., Feb. 24 – Pfizer Inc. priced $1,065,000,000 of 4.2% 30-year notes (A1/AA) at par on Friday, according to an FWP filing with the Securities and Exchange Commission.

BNP Paribas, Taipei Branch, and Deutsche Bank AG, Taipei Branch, were the bookrunners.

The company will apply to list the notes on the Taipei Exchange.

Proceeds will be used for general corporate purposes, including to repay a portion of outstanding commercial paper. As of Feb. 22, Pfizer had about $6.6 billion of outstanding commercial paper.

The biopharmaceutical company is based in New York.

Issuer:	Pfizer Inc.
Amount:	$1,065,000,000
Description:	Notes
Maturity:	March 17, 2047
Bookrunners:	BNP Paribas, Taipei Branch, and Deutsche Bank AG, Taipei Branch,
Structuring agents:	Deutsche Bank, Citigroup Global Markets Inc., HSBC Securities (USA) Inc., Mizuho Securities USA Inc., Morgan Stanley & Co. LLC, Standard Chartered Bank
Co-structuring agents:	Academy Securities, Inc., Siebert Brandford Shank & Co., LLC, Williams Capital Group, LP
Coupon:	4.2%
Price:	Par
Yield:	4.2%
Call feature:	Every March 17 on or after March 17, 2020 at par
Trade date:	Feb. 24
Settlement date:	March 17
Ratings:	Moody’s: A1
	S&P: AA
Distribution:	SEC registered

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.